Go Unlimited with Magzter GOLD
Get unlimited access to 10,000+ magazines, newspapers and Premium stories for just
Try GOLD - Free
PE firm InvAscent keen to list five portfolio companies
Mint Mumbai
|January 04, 2024
Private equity firm InvAscent is preparing to list five portfolio companies across health and pharmaceuticals segments over the next 24-36 months, as the firms achieve scale, chairman and managing director Hari Buggana said in an interview.
-
These portfolio firms include drug companies Symbiotec Pharmalab Ltd and Malladi Drugs, women and child-focused Ankura Hospital, healthcare devices business Accumax Lab Devices Pvt. Ltd, and digital health-tech platform MediBuddy, he said.
The public listing of these portfolio firms will open up exit opportunities for healthcare and pharmaceuticals-focused investor.
"An additional exit opportunity has opened up for us through the capital markets this is a shift in our strategy. In the past, our exits have been to other financial investors or strategics," Buggana said.
InvAscent is invested in these five portfolio firms from India Life Sciences Fund III, which was sized at around $350 million.
This story is from the January 04, 2024 edition of Mint Mumbai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Mumbai
Mint Mumbai
Nelco crosses first step to satcom reselling licence
Tata Group-owned Nelco Ltd has received the government's preliminary approval to resell satellite internet services to consumers by partnering with companies such as Elon Musk’s Starlink, OneWeb, Amazon's Kuiper and Jio Satellite, according to three people in the know.
3 mins
October 02, 2025
Mint Mumbai
WHAT A YEAR AT COLUMBIA TAUGHT ME
An Indian journalist at Columbia University navigated a tumultuous year, learning unusual life lessons
8 mins
October 02, 2025
Mint Mumbai
Festive demand, tax cut power up auto sales in Sep
Powered by tax cuts and festive spirits, automobile sales took off in September, cheering manufacturers across the board.
3 mins
October 02, 2025
Mint Mumbai
Central bank seen keeping its options open on Tata Sons IPO
A day after the Reserve Bank of India's deadline for the Tata Group to list its holding company, Tata Sons, passed, the central bank appears to be still weighing its decision, with governor Sanjay Malhotra's comment leaving the matter open to interpretation.
2 mins
October 02, 2025
Mint Mumbai
US trade pact close, comprehensive deal to sidestep patents
As India and the US inch closer to the timeline to finalize a trade deal, both sides are moving towards signing a comprehensive Bilateral Trade Agreement (BTA) that will cover nearly every aspect of commerce, from tariff reduction and easing of non-tariff barriers to expanded access in services and energy cooperation.
2 mins
October 02, 2025
Mint Mumbai
RBI unveils plans to bolster credit flow to corporates, capital market
Regulator to remove cap on banks’ market lending to single group, proposes to allow acquisition funding
2 mins
October 02, 2025
Mint Mumbai
Cough syrup kills 6 children in MP; govt begins probe
Early reports suggest the syrups may have been tainted with diethylene glycol, a toxic chemical
1 mins
October 02, 2025
Mint Mumbai
Prez Trump's proposed changes to visa rules assailed by chip industry
The F-1 student visa serves as a critical pipeline to the tech workforce
4 mins
October 02, 2025
Mint Mumbai
Top firms tick boxes, but lag on diversity, independence
India's top 100 listed companies have shown progress in corporate governance practices, but persistent gaps remain in board meeting attendance, diversity, and leadership independence.
2 mins
October 02, 2025
Mint Mumbai
RBI rate actions are signals that markets need not always heed
Contrary to widespread belief, monetary transmission is both slower and far-from-linear, globally
3 mins
October 02, 2025
Translate
Change font size